Kiyoshi Itagaki1, Ingred Riça, Jing Zhang, Dave Gallo, Melissa DePrato, Leo E Otterbein, Carl J Hauser. 1. From Beth Israel Deaconess Medical Center, Harvard Medical School (K.I., I.R., J.Z., D.G., M.D., L.E.D., C.J.H.), Boston, Massachusetts; Koch Institute, Massachusetts Institute of Technology (I.R.), Cambridge, Massachusetts; Tanjin Medical University (J.Z.), China.
Abstract
BACKGROUND: Nosocomial pneumonias are common in trauma patients and so interventions to prevent and treat nosocomial pneumonia may improve outcomes. Our prior work strongly suggests that tissue injury predisposes to infections like nosocomial pneumonia because mitochondrial debris originating from injured cells contains damage-associated molecular patterns that can reduce neutrophil (PMN) migration into the airway and diminish PMN function in response to bacterial inoculation of the airway. This suggested that putting exogenous "normal" PMN into the airway might be beneficial. METHODS: Postinjury pneumonia (PNA) commonly arises in two groups, early, community-acquired PNA (CAP) and later hospital-acquired PNA (HAP). Posttraumatic early-onset CAP and late-onset HAP were modeled in CD-1 mice using Staphylococcus aureus or Pseudomonas aeruginosa instilled intratracheal (i.t.) at clinically relevant times with or without extrapulmonary injuries mimicked by an intraperitoneal application of mitochondrial damage-associated molecular patterns. We applied bone marrow-derived PMN (BM-PMN) intratracheally to assess their effect on bacterial clearance in the lung. RESULTS: BM-PMN instillation i.t. had no untoward clinical effects on recipient animals. In both the early/CAP and late/HAP models, clearance of the bacterial inoculum from the lung was suppressed by mitochondrial debris and restored to uninjured levels by i.t. instillation of exogenous BM-PMN. Furthermore, PMN instillation cleared the inoculum of P. aeruginosa that could not be cleared by uninjured mice. Instillation of PMN into the lung, even across strains (CD-1 vs. C57BL/6) had no injurious effect. CONCLUSION: These initial studies suggest PMN instillation (i.t.) is worthy of further study as a potential adjunctive therapy aimed at decreasing the morbidity of lung infections in trauma patients. Moreover, PMN instillation (i.t.) may represent a unique means of preventing or treating pneumonia after serious injury that is completely independent of the need for antibiotic use.
BACKGROUND:Nosocomial pneumonias are common in traumapatients and so interventions to prevent and treat nosocomial pneumonia may improve outcomes. Our prior work strongly suggests that tissue injury predisposes to infections like nosocomial pneumonia because mitochondrial debris originating from injured cells contains damage-associated molecular patterns that can reduce neutrophil (PMN) migration into the airway and diminish PMN function in response to bacterial inoculation of the airway. This suggested that putting exogenous "normal" PMN into the airway might be beneficial. METHODS:Postinjury pneumonia (PNA) commonly arises in two groups, early, community-acquired PNA (CAP) and later hospital-acquired PNA (HAP). Posttraumatic early-onset CAP and late-onset HAP were modeled in CD-1mice using Staphylococcus aureus or Pseudomonas aeruginosa instilled intratracheal (i.t.) at clinically relevant times with or without extrapulmonary injuries mimicked by an intraperitoneal application of mitochondrial damage-associated molecular patterns. We applied bone marrow-derived PMN (BM-PMN) intratracheally to assess their effect on bacterial clearance in the lung. RESULTS: BM-PMN instillation i.t. had no untoward clinical effects on recipient animals. In both the early/CAP and late/HAP models, clearance of the bacterial inoculum from the lung was suppressed by mitochondrial debris and restored to uninjured levels by i.t. instillation of exogenous BM-PMN. Furthermore, PMN instillation cleared the inoculum of P. aeruginosa that could not be cleared by uninjured mice. Instillation of PMN into the lung, even across strains (CD-1 vs. C57BL/6) had no injurious effect. CONCLUSION: These initial studies suggest PMN instillation (i.t.) is worthy of further study as a potential adjunctive therapy aimed at decreasing the morbidity of lung infections in traumapatients. Moreover, PMN instillation (i.t.) may represent a unique means of preventing or treating pneumonia after serious injury that is completely independent of the need for antibiotic use.
Authors: Michael H Tarlowe; Andrew Duffy; Kollenkode B Kannan; Kiyoshi Itagaki; Robert F Lavery; David H Livingston; Paul Bankey; Carl J Hauser Journal: Am J Respir Crit Care Med Date: 2004-12-23 Impact factor: 21.405
Authors: Kiyoshi Itagaki; Elzbieta Kaczmarek; Yen Ting Lee; I Tien Tang; Burak Isal; Yashar Adibnia; Nicola Sandler; Melissa J Grimm; Brahm H Segal; Leo E Otterbein; Carl J Hauser Journal: PLoS One Date: 2015-03-16 Impact factor: 3.240
Authors: Matteo Bassetti; Jan J De Waele; Philippe Eggimann; Josè Garnacho-Montero; Gunnar Kahlmeter; Francesco Menichetti; David P Nicolau; Jose Arturo Paiva; Mario Tumbarello; Tobias Welte; Mark Wilcox; Jean Ralph Zahar; Garyphallia Poulakou Journal: Intensive Care Med Date: 2015-03-20 Impact factor: 17.440
Authors: Kiyoshi Itagaki; Elzbieta Kaczmarek; Woon Yong Kwon; Li Chen; Barbora Vlková; Quanzhi Zhang; Ingred Riça; Michael B Yaffe; Yan Campbell; Michael F Marusich; Ji Ming Wang; Wang-Hua Gong; Ji-Liang Gao; Françoise Jung; Garry Douglas; Leo E Otterbein; Carl J Hauser Journal: Crit Care Med Date: 2020-02 Impact factor: 7.598
Authors: Julie Ng; Fei Guo; Anna E Marneth; Sailaja Ghanta; Min-Young Kwon; Joshua Keegan; Xiaoli Liu; Kyle T Wright; Baransel Kamaz; Laura A Cahill; Ann Mullally; Mark A Perrella; James A Lederer Journal: Blood Adv Date: 2020-10-13